Genetic risk for schizophrenia is linked to retinal thinning, offering new insights into early detection and prevention ...

ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the“Company”) recently announced U.S. FDA approval of its innovative yield enhancement production process. This innovative process has demonstrated an ...

A man who put his type 2 diabetes in remission in just 12 months has shared the signs you may be pre-diabetic, and they may ...

New research suggests a path forward that could change the lives of millions who are losing vision due to retinal damage and conditions like macular degeneration and glaucoma.

A man who is in remission for type 2 diabetes has shared that there are five signs you should look out for if you're ...

Todd Engels, 62, from Maryland, started taking Ozempic after he saw glowing headlines and slick ads praising it as a 'miracle ...

As trade tensions show signs of easing, European markets have experienced a positive uptick, with the STOXX Europe 600 Index climbing 2.77% and major indices like Germany's DAX and France's CAC 40 ...

At the recent SEC meeting for Ophthalmology held on 19th March 2025, the expert panel reviewed the proposal to conduct a ...

Q1 2025 Earnings Call Transcript April 29, 2025 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

Stocks closed higher Tuesday to extend a week-long rally as investors digested a flurry of earnings reports from major ...

Researchers evaluate key measures for tracking disease progression in Usher syndrome type 2–related retinal degeneration ...

Discover the details about Wegovy, a popular weight loss drug now available for telehealth purchase. Understand its benefits, ...